Peripartum and Postpartum Management of Diabetes

Similar documents
PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Diabetes in Pregnancy

Intrapartum and Postpartum Management of the Diabetic Mother and Infant

Vishwanath Pattan Endocrinology Wyoming Medical Center

LIBERTYHEALTH. Jersey City Medical Center Department of Patient Care Services. Approved by Policy Committee:

DRUG ALLERGIES WT: KG

Current Trends in Diagnosis and Management of Gestational Diabetes

Pharmacy Plan Guidance

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.

Diabetes in Pregnancy

SHINE Study PowerChart Order Set CONTROL

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Management of Pregestational and Gestational Diabetes Mellitus

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI

A Children s Bedtime Story

DIABETES WITH PREGNANCY

GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked

Diabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System

Diabetes in Pregnancy

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations. Askiel Bruno, MD, MS Protocol PI

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad

MANAGEMENT OF DIABETES IN PREGNANCY

Special Situations 1

The Ever-Changing Approaches to Diabetes in Pregnancy

Diabetes Related Disclosures

PHYSICIAN S ORDERS Page 1 of 1 Providence Hospital ICU Insulin Drip Protocol

Intensive Insulin in the Intensive Care Unit

Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes

Nph insulin conversion to lantus

How to BBIT An Educational Resource for Prescribers AHS Adult Subcutaneous Basal Bolus Insulin Therapy (BBIT)

Optimizing Care of the Inpatient with Hyperglycemia and Diabetes: Case Studies in Action

APPENDIX American Diabetes Association. Published online at

2018 Standard of Medical Care Diabetes and Pregnancy

4/10/2015. Foundations to Managing Inpatient Hyperglycemia. Learning Objectives

In - Hospital Diabetes Care. A review and personal experience

HAP PA-HEN Achieving More Together

Pregestational Diabetes in Pregnancy. An Update

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE

Glucose Management in the ICU: The Role of the Pharmacist

Using the Bolus Wizard Calculator

Improving Outcomes in Pregnancies Complicated by Diabetes Mellitus

Significant economic burden Conservative because focus on near-term medical costs, omitting increased long-term risks Insulin Resistance

DKA Adult ICU Powerplan

Diabetes in obstetric patients

APEC Guidelines Gestational Diabetes Mellitus

Diabetes in Pregnancy

Disclosures. Diagnosis and Management of Diabetes in Pregnancy. I have nothing to disclose. Type 1. Overview GDMA1

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial

Diabetes and Pregnancy

Glycemic Control IU Health Diabetes Centers

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin

SARASOTA MEMORIAL HOSPITAL

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

Diabetes in Pregnancy. L.Sekhavat MD

Managing Diabetes Before, During, and After Pregnancy

Faculty. Disclosures. Prescribing. A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy. Learning Objectives

Report Reference Guide

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς

Diabetes from Antepartum to Postpartum:

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes

Management of Gestational Diabetes

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE

Diabetes: Intrapartum and Post Natal Policy

Information for all patients taking insulin who are admitted to hospital on day of surgery

Managing Diabetes and Hyperglycemia Safely in the Complex Hospital Setting

PAPER. Glycemic Control and Reduction of Deep Sternal Wound Infection Rates

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Gestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program

Care of Students with Diabetes

Let s not sugar coat it: Promoting excellence in glucose control in hospitalized and perioperative patients WELCOME!

Insulin Prior Authorization with optional Quantity Limit Program Summary

GESTATIONAL DIABETES TESTING AND TREAMENT

BPA exposure during pregnancy: risk for gestational diabetes and diabetes following pregnancy

SCHOOL HEALTH PLAN: DIABETES

Diabetes & Pregnancy: Management Guide

Diagnosis and Management of Gestational Diabetes Mellitus. Prof. Dr Md Faizul Islam Chowdhury Professor of Medicine, Department of Medicine, DMCH.

Fine-tuning of The Dose of Insulin Pump

Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting:

Perioperative Glycemic Control Implementation

Managing Gestational Diabetes. Definition of GDM

Pump Basics for the School Nurse. Children's Endocrinology Center of Dallas

Pregnancy and Diabetes

Care of Students with Diabetes

PRACTICE GUIDELINES WOMEN S HEALTH PROGRAM

4/2/2018 MOVING THROUGH PREGNANCY WITH TECHNOLOGY CLINICAL EXPERIENCE WITH PUMPS, CGMS AND THE HYBRID CLOSED LOOP CONFLICT OF INTEREST DISCLOSURE

Glycemic Control Insulin In The Hospital Setting

Objectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy

Learning Objectives. Perioperative SWEET Success

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

Chapter 37: Exercise Prescription in Patients with Diabetes

Transcription:

Peripartum and Postpartum Management of Diabetes General Principles Glucose goal ~ 100 mg/dl (70-110 mg/dl) Labor is EXERCISE with increased metabolic demands. Insulin requirements decrease however the stress response of labor contributes to a more insulin-resistant state. Elevated maternal glucose contributes to neonatal hypoglycemia. ALL women with diabetes (including GDMA1) should have glucose checks upon admission and every 1-2 hours during active labor and every 1 hour if on insulin drip. Note: GDMA1 and A2 rarely require insulin in labor. Before Admission Home regimen Usual NPH dose in the evening before admission. T2DM: 1/2 NPH dose in am if induction and no NPH if cesarean. T1DM: 1/3 NPH dose in am or if insulin pump continue pump settings. For long acting glargine (lantus) administer 1/3 dose at bedtime For evening admission, take usual insulin regimen during the day including evening NPH. Admission

IV Insulin Management 1. Initiate the insulin drip starting at Algorithm 2 (do not start at algorithm level >2) 2. Adjust the Rate According to the Following Criteria: If the present BG level has declined by more 100 mg/dl in one hour, move down to the next lesser algorithm. If already using Algorithm 1, decrease insulin infusion by half. If the previous BG was greater 200 mg/dl and the present BG has not decreased by at least 60 mg/dl in one hour (or there is an increase), move up to the next Algorithm. If the previous BG was 140-200 mg/dl and the present BG has not decreased by at least 30 mg/dl (or there is an increase) in one hour, move up to the next Algorithm. If the previous BG was 110-139 mg/dl and the present BG has not decreased by at least 15 mg/dl (or there is an increase) in one hour, move up to the next Algorithm. If the present BG level is less 70 mg/dl, treat hypoglycemia and move down to the next lesser Algorithm. If already using Algorithm 1, decrease insulin infusion by half. (See next page for hypoglycemia management.) If the present BG is 70-109, continue in the same Algorithm and adjust the rate as indicated. Algorithm 1 Algorithm 2 Algorithm 3 Algorithm 4 Algorithm 5 Algorithm 6 BG Rate BG Rate BG Rate BG Rate BG Rate BG Rate Less Off Less Off Less Off Less Off Less Off Less Off 70 70 70 70 70 70 70-109 0.2 70-109 0.5 70-109 1 70-109 1.5 70-109 2 70-109 3 110-124 0.5 110-124 1 110-124 2 110-124 3 110-124 5 110-124 8 125-149 1 125-149 1.5 125-149 3 125-149 5 125-149 8 125-149 13 150-179 1.5 150-179 2 150-179 4 150-179 7 150-179 12 150-179 18 180-209 2 180-209 3 180-209 5 180-209 9 180-209 15 180-209 23 210-239 2 210-239 4 210-239 6 210-239 12 210-239 18 210-239 28 240-269 3 240-269 5 240-269 8 240-269 16 240-269 24 240-269 36 270-299 3 270-299 6 270-299 10 270-299 20 270-299 30 270-299 45 300-329 4 300-329 7 300-329 12 300-329 24 300-329 39 300-329 58 330-359 4 330-359 8 330-359 14 330-359 28 330-359 40 330-359 66 6 12 16 28 40 66

Patient Monitoring: Bedside blood glucose monitoring every hour until stable between 70-109 mg/dl for four consecutive hours then decrease to every 2 hours. Resume hourly blood glucose monitoring with any of the following: Change in insulin drip rate Significant change in clinical status Change in nutritional support, Glucocorticoid supplementation Hypoglycemia Management: If blood sugar is less 70 mg/dl, STOP THE INFUSION. Notify the. Give 15 grams of PO carbohydrate. Recheck blood glucose every 15 minutes. Restart insulin infusion using the next lesser Algorithm when blood glucose is greater 85 mg/dl. If already using Algorithm 1, decrease the infusion by half. If blood glucose is less 50 mg/dl, STOP THE INFUSION. Notify. If patient alert and able to take fluids, give 15 grams of PO carbohydrate. If patient confused or unconscious or NPO, give 25 ml of 50 % dextrose IV. Recheck blood glucose every 15 minutes. Repeat PO carbohydrate or IV 50 % dextrose every 15 minutes until the blood glucose is greater 70 mg/dl. Resume insulin infusion at the next lesser Algorithm when blood glucose is greater 85 mg/dl. If already using Algorithm 1, decrease the infusion by half. Notify the Physician and Document: Any blood glucose change of greater 100mg/dl in 1 hour If BG is < 70 mg/dl If BG is > 250 mg/dl If BG is not controlled on Algorithm 6 Any hypoglycemia unresolved within 30 minutes of stopping insulin drip When advance in algorithms do not result in targeted BG levels Transitions off Insulin Drip: Stop drip after delivery of the placenta for GDM/T2DM. If IV insulin is to be continued, algorithm should be cut in half until patient is able to tolerate PO carbohydrate intake. When intermediate or long acting insulin can be started, proceed as follows: give the long acting insulin and continue monitoring the blood glucose every hour for at least 2 hours before discontinuing the drip.

Postpartum Glucose Monitoring KEY: Breastfeeding decreases the likelihood of mothers with GDM developing T2DM within the next 2 years by 53% and next 19 years by 40% Up to 30% of women with GDM continue to have glucose impairment 50-70% risk of developing T2DM in the next 5-10 years 2 hours postprandial goal is 100-160 mg/dl and avoidance of HYPOGLYCEMIA, NOT tight pregnancy control Gestational Diabetes Fasting POC glucose on postpartum day #1 <100 No further testing after discharge 100-125 Prediabetic counselling PP 126 but <200 Resume diabetic diet and fasting/premeal POC glucose; refer to primary care physician to manage until PP diagnostic testing (6 weeks PP) 200 Consult Diabetes Service or primary care before discharge; PP follow-up with PCP or Endocrinology Pregestational Diabetes T2DM, oral meds: POC glucose q4 hours postop until intake is normal, and may then resume normal checks/prepregnancy meds. Metformin is contraindicated for at least 48 hours after surgery. Insulin SQ: Return to prepregnancy regimen if T2DM T1DM usually 60-70% of prepregnancy doses (determined by Rhonda Fruhling, ARNP Med Endo) Insulin pump: Restart after delivery. If delivered at night, EITHER 50% of late pregnancy OR pre-pregnancy settings may be used (determined by primary diabetes provider) Breastfeeding mothers may require lower doses while breastfeeding and should be counseled to watch for hypoglycemia.

References: http://perinatology.com/reference/cdapp%20ss%20guidelines%202012.pdf https://www.ohsu.edu/xd/health/services/women/for-healthcare-providers/upload/cwh- 21473169-DAPP-Guideline-FINAL-lo-res.pdf St. Mary s Hospital, Madison, WI Mayo Clinic, Rochester, MN